Substituted imidazo[2,1-b]thiazole compounds and uses thereof
申请人:Gruenenthal GmbH
公开号:US07893069B2
公开(公告)日:2011-02-22
Substituted imidazo[2,1-b]thiazole compounds corresponding to formula I,
a method for producing them, pharmaceutical compositions containing them, and the use thereof for regularing mGluR5 receptors, or for treating or inhibiting disorders or disease states at least partially mediated by mGluR5 receptor such as pain, anxiety attacks, drug or alcohol dependency, and others.
SUBSTITUIERTE IMIDAZO(2,1-B)THIAZOL-VERBINDUNGEN UND IHRE VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN
申请人:Grünenthal GmbH
公开号:EP1996596B1
公开(公告)日:2015-07-08
US7893069B2
申请人:——
公开号:US7893069B2
公开(公告)日:2011-02-22
[DE] SUBSTITUIERTE IMIDAZO[2,1-B]THIAZOL-VERBINDUNGEN UND IHRE VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN<br/>[EN] SUBSTITUTED IMIDAZO[2,1-B]THIAZOLE COMPOUNDS AND THEIR USE FOR PRODUCING DRUGS<br/>[FR] COMPOSÉS IMIDAZO[2,1-B]THIAZOLE SUBSTITUÉS ET UTILISATION DANS LA FABRICATION DE MÉDICAMENTS
申请人:GRUENENTHAL GMBH
公开号:WO2007104485A2
公开(公告)日:2007-09-20
[EN] The invention relates to substituted imidazo[2,1-b]thiazole compounds of formula (I) and to methods for producing them, to drugs containing said compounds and to their use for producing drugs. [FR] L'invention concerne des composés imidazo[2,1-b]thiazole substitués, représentés par la formule (I), des procédés de fabrication de ces composés, des médicaments les contenant et leur utilisation dans la fabrication de médicaments. [DE] Die vorliegende Erfindung betrifft substituierte Imidazo[2,1-b]thiazol-Verbindungen der allgemeinen Formel (I), Verfahren zu ihrer Herstellung, Arzneimittel enthaltend diese Verbindungen sowie deren Verwendung zur Herstellung von Arzneimitteln.
Substituted Imidazo[2,1-b]thiazole Compounds and Uses Thereof
申请人:KUEHNERT Sven
公开号:US20090005399A1
公开(公告)日:2009-01-01
Substituted imidazo[2,1-b]thiazole compounds corresponding to formula I,
a method for producing them, pharmaceutical compositions containing them, and the use thereof for regularing mGluR5 receptors, or for treating or inhibiting disorders or disease states at least partially mediated by mGluR5 receptor such as pain, anxiety attacks, drug or alcohol dependency, and others.